Cargando…

Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID‐19

Cognitive post‐acute sequelae of SARS‐CoV‐2 (PASC) can occur after mild COVID‐19. Detailed clinical characterizations may inform pathogenesis. We evaluated 22 adults reporting cognitive PASC and 10 not reporting cognitive symptoms after mild SARS‐CoV‐2 infection through structured interviews, neurop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Apple, Alexandra C., Oddi, Alexis, Peluso, Michael J., Asken, Breton M., Henrich, Timothy J., Kelly, J. Daniel, Pleasure, Samuel J., Deeks, Steven G., Allen, Isabel Elaine, Martin, Jeffrey N., Ndhlovu, Lishomwa C., Miller, Bruce L., Stephens, Melanie L., Hellmuth, Joanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2022
Materias:	Brief Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862406/ https://www.ncbi.nlm.nih.gov/pubmed/35043593 http://dx.doi.org/10.1002/acn3.51498

Ejemplares similares

Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients
por: Hellmuth, Joanna, et al.
Publicado: (2021)

Elevated Cerebrospinal Fluid Anti-CD4 Autoantibody Levels in HIV Associate with Neuroinflammation
por: Cheng, Da, et al.
Publicado: (2022)

Cerebrospinal fluid soluble CD30 elevation despite suppressive antiretroviral therapy in individuals living with HIV-1
por: Peluso, Michael J, et al.
Publicado: (2020)

Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease
por: Sweeney, Melanie D, et al.
Publicado: (2015)

Cerebrospinal fluid and plasma neurofilament light relate to abnormal cognition
por: Osborn, Katie E., et al.
Publicado: (2019)

Brain heterotopia formation by ciliopathic breakdown of neuroepithelial and blood‐cerebrospinal fluid barriers
por: Jung, Hyun Jin, et al.
Publicado: (2023)

A High Percentage of People With Human Immunodeficiency Virus (HIV) on Antiretroviral Therapy Experience Detectable Low-Level Plasma HIV-1 RNA Following Coronavirus Disease 2019 (COVID-19)
por: Peluso, Michael J, et al.
Publicado: (2020)

Identifying degenerative effects of repetitive head trauma with neuroimaging: a clinically-oriented review
por: Asken, Breton M., et al.
Publicado: (2021)

Cerebrospinal fluid HIV infection and pleocytosis: Relation to systemic infection and antiretroviral treatment
por: Spudich, Serena S, et al.
Publicado: (2005)

Booster vaccines for COVID-19 vaccine breakthrough cases?
por: Nixon, Douglas F, et al.
Publicado: (2022)

A consensus on the classification of hydrocephalus: its utility in the assessment of abnormalities of cerebrospinal fluid dynamics
por: Rekate, Harold L.
Publicado: (2011)

Central Nervous System Effects of COVID-19 in People with HIV Infection
por: Peluso, Michael J., et al.
Publicado: (2021)

Racial Disparity in Cerebrospinal Fluid Amyloid and Tau Biomarkers and Associated Cutoffs for Mild Cognitive Impairment
por: Garrett, Stephanie L., et al.
Publicado: (2019)

Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
por: Visser, Pieter Jelle, et al.
Publicado: (2022)

The latent HIV reservoir: current advances in genetic sequencing approaches
por: Moar, Preeti, et al.
Publicado: (2023)

Diet Effects on Cerebrospinal Fluid Amino Acids Levels in Adults with Normal Cognition and Mild Cognitive Impairment
por: Russin, Kate J., et al.
Publicado: (2021)

A machine learning approach utilizing DNA methylation as an accurate classifier of COVID-19 disease severity
por: Bowler, Scott, et al.
Publicado: (2022)

Using Cerebrospinal Fluid Biomarker Testing to Target Treatment to Patients with Mild Cognitive Impairment: A Cost-Effectiveness Analysis
por: Michaud, Tzeyu L., et al.
Publicado: (2017)

Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
por: Visser, Pieter Jelle, et al.
Publicado: (2022)

Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer's Disease in Amnestic Mild Cognitive Impairment
por: Park, Jung Eun, et al.
Publicado: (2019)

Abnormal Expression of Cerebrospinal Fluid Cation Chloride Cotransporters in Patients with Rett Syndrome
por: Duarte, Sofia Temudo, et al.
Publicado: (2013)

Cerebrospinal fluid abnormalities in meningeosis neoplastica: a retrospective 12-year analysis
por: Djukic, Marija, et al.
Publicado: (2017)

The cerebrospinal fluid in retinoblastoma.
por: Ifekwunigwe, A. E., et al.
Publicado: (1966)

Cerebrospinal Fluid MicroRNA Changes in Cognitively Normal Veterans With a History of Deployment-Associated Mild Traumatic Brain Injury
por: Lusardi, Theresa A., et al.
Publicado: (2021)

Differences in Post-mRNA Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunoglobulin G (IgG) Concentrations and Surrogate Virus Neutralization Test Response by Human Immunodeficiency Virus (HIV) Status and Type of Vaccine: A Matched Case-Control Observational Study
por: Spinelli, Matthew A, et al.
Publicado: (2021)

A selenium species in cerebrospinal fluid predicts conversion to Alzheimer’s dementia in persons with mild cognitive impairment
por: Vinceti, Marco, et al.
Publicado: (2017)

Role of Natural Killer Cells in HIV-Associated Malignancies
por: Leal, Fabio E., et al.
Publicado: (2017)

LB8. Lower SARS-CoV-2 IgG and Pseudovirus Neutralization Titers Post-mRNA Vaccination among People Living with HIV
por: Spinelli, Matthew A, et al.
Publicado: (2021)

Cerebrospinal Fluid Metabolomics: Pilot Study of Using Metabolomics to Assess Diet and Metabolic Interventions in Alzheimer’s Disease and Mild Cognitive Impairment
por: Hanson, Angela J., et al.
Publicado: (2023)

SAT-382 Pyridoxal 5’-Phosphate Cerebrospinal Fluid Abnormalities in Hyopophosphatasia Before and After Enzyme Replacement Therapy
por: Wright, Jordan J, et al.
Publicado: (2020)

Cerebrospinal Fluid Homer-3 Autoantibodies in a Patient with Amnestic Mild Cognitive Impairment
por: Hansen, Niels, et al.
Publicado: (2023)

Selenium Species in Cerebrospinal Fluid and Hippocampal Volume among Individuals with Mild Cognitive Impairment
por: Vinceti, Marco, et al.
Publicado: (2022)

Characteristic abnormalities in cerebrospinal fluid biochemistry in children with cerebral malaria compared to viral encephalitis
por: Jakka, SR, et al.
Publicado: (2006)

Cerebrospinal Fluid Biomarkers for Dementia with Lewy Bodies
por: Mukaetova-Ladinska, Elizabeta B., et al.
Publicado: (2010)

Cerebrospinal fluid biomarkers in Parkinson’s disease with freezing of gait: an exploratory analysis
por: Hatcher-Martin, J. M., et al.
Publicado: (2021)

Entamoeba histolytica meningoencephalitis diagnosed by trophozoites in cerebrospinal fluid
por: Goh, L M L, et al.
Publicado: (2013)

Association of imaging abnormalities of the subcallosal septal area with Alzheimer's disease and mild cognitive impairment
por: Gan, C.L., et al.
Publicado: (2017)

T-Cell Subsets in the Cerebrospinal Fluid and Peripheral Blood of Patients with Parkinson's Disease
por: Pavón, N., et al.
Publicado: (1992)

Concordant and Discordant Cerebrospinal Fluid and Plasma Cytokine and Chemokine Responses in Mild Cognitive Impairment and Early-Stage Alzheimer’s Disease
por: de la Monte, Suzanne M., et al.
Publicado: (2023)

Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infection
por: Gisslén, Magnus, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_qheeq8qfk0mj2kvhhnccbfbr1l